These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18855573)

  • 61. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
    Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
    Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ; Dehnade F; Zafarullah M
    J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
    [TBL] [Abstract][Full Text] [Related]  

  • 63. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway].
    Yu X; Wan QL; Li Z; Li ZB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985
    [No Abstract]   [Full Text] [Related]  

  • 65. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
    Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
    Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
    Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
    Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling.
    Che Y; Hou S; Kang Z; Lin Q
    Oncol Rep; 2009 Aug; 22(2):377-83. PubMed ID: 19578780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
    Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
    Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells.
    Yu JH; Kim KH; Kim H
    Biochem Pharmacol; 2006 Nov; 72(11):1555-62. PubMed ID: 16934228
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer.
    Jin J; Guo Q; Xie J; Jin D; Zhu Y
    Pathol Oncol Res; 2019 Apr; 25(2):769-775. PubMed ID: 30706361
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors.
    Minus MB; Wang H; Munoz JO; Stevens AM; Mangubat-Medina AE; Krueger MJ; Liu W; Kasembeli MM; Cooper JC; Kolosov MI; Tweardy DJ; Redell MS; Ball ZT
    Org Biomol Chem; 2020 May; 18(17):3288-3296. PubMed ID: 32286579
    [TBL] [Abstract][Full Text] [Related]  

  • 75. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
    Tyner JW; Walters DK; Willis SG; Luttropp M; Oost J; Loriaux M; Erickson H; Corbin AS; O'Hare T; Heinrich MC; Deininger MW; Druker BJ
    Blood; 2008 Feb; 111(4):2238-45. PubMed ID: 18025156
    [TBL] [Abstract][Full Text] [Related]  

  • 76. JAK/STAT3 signaling pathway mediates endothelial-like differentiation of immature dendritic cells.
    Jin G; Zhao J; Yang YI; Liu K; Jiang Y; Zhang X; Zhang Y; Huang Y; Lu J; Dong Z
    Oncol Lett; 2015 Dec; 10(6):3471-3477. PubMed ID: 26788152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of growth hormone on endometrium growth of intrauterine adhesion and the underlying mechanism.
    Feng Q; Zhang A; Xu D; Zeng F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1522-1531. PubMed ID: 36481630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Electroacupuncture Improves Blood Pressure in SHRs by Regulating the Immune Balance between Th17 and Treg.
    Wang Y; Zhang L; Li L; Hu H; Pan P; Zhang B; Ning W; Zhao M; Wang S
    Evid Based Complement Alternat Med; 2020; 2020():5375981. PubMed ID: 32724324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.
    Lv M; Ou R; Zhang Q; Lin F; Li X; Wang K; Xu Y
    Drug Des Devel Ther; 2019; 13():2371-2379. PubMed ID: 31409971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer.
    Rucki AA; Foley K; Zhang P; Xiao Q; Kleponis J; Wu AA; Sharma R; Mo G; Liu A; Van Eyk J; Jaffee EM; Zheng L
    Cancer Res; 2017 Jan; 77(1):41-52. PubMed ID: 27821486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.